Hematopoietic Cell Transplantation for Systemic Sclerosis-A Review

被引:7
作者
Levin, Daniel [1 ]
Osman, Mohammed S. [2 ]
Durand, Caylib [1 ]
Kim, Hyein [3 ]
Hemmati, Iman [3 ]
Jamani, Kareem [1 ]
Howlett, Jonathan G. [1 ]
Johannson, Kerri A. [1 ]
Weatherald, Jason [1 ,2 ]
Woo, Matthew [1 ]
Lee, Jason [1 ]
Storek, Jan [1 ]
机构
[1] Univ Calgary, Cumming Sch Med, Calgary, AB T2N 4N1, Canada
[2] Univ Alberta, Fac Med, Edmonton, AB T6G 2R7, Canada
[3] Univ British Columbia, Fac Med, Vancouver, BC V6T 1Z3, Canada
关键词
systemic sclerosis; hematopoietic stem cell transplant; sclerosis; ILD; TERM-FOLLOW-UP; AUTOIMMUNE-DISEASES; MARROW-TRANSPLANTATION; MULTIPLE-SCLEROSIS; BONE-MARROW; PULSE CYCLOPHOSPHAMIDE; IMMUNE RECONSTITUTION; CONDITIONING REGIMEN; ENGRAFTMENT SYNDROME; PERIPHERAL-BLOOD;
D O I
10.3390/cells11233912
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Systemic sclerosis (SSc) is an autoimmune, multi-organ, connective tissue disease associated with significant morbidity and mortality. Conventional immunosuppressive therapies demonstrate limited efficacy. Autologous hematopoietic stem cell transplantation (HCT) is more efficacious but carries associated risks, including treatment-related mortality. Here, we review HCT as a treatment for SSc, its efficacy and toxicity in comparison to conventional therapies, and the proposed mechanisms of action. Furthermore, we discuss the importance of and recent developments in patient selection. Finally, we highlight the knowledge gaps and future work required to further improve patient outcomes.
引用
收藏
页数:26
相关论文
共 159 条
[1]   Scleroderma-associated cutaneous calcinosis: a remarkable regression post stem cell transplantation [J].
Abdalla, Abuelmagd ;
Khalid, Muhammad ;
Ishaq, Qasim ;
Donnelly, Suzanne .
CLINICAL RHEUMATOLOGY, 2021, 40 (02) :789-790
[2]   Long term outcomes of the French ASTIS systemic sclerosis cohort using the global rank composite score [J].
Abdallah, Nassim Ait ;
Wang, Mianbo ;
Lansiaux, Pauline ;
Puyade, Mathieu ;
Berthier, Sabine ;
Terriou, Louis ;
Charles, Catney ;
Burt, Richard K. ;
Hudson, Marie ;
Farge, Dominique .
BONE MARROW TRANSPLANTATION, 2021, 56 (09) :2259-2267
[3]   Determinants of Morbidity and Mortality of Systemic Sclerosis in Canada [J].
Al-Dhaher, Firas F. ;
Pope, Janet E. ;
Ouimet, Janine M. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2010, 39 (04) :269-277
[4]   Hematopoietic Stem Cell Transplantation for Autoimmune Disease [J].
Alexander, Tobias ;
Greco, Raffaella ;
Snowden, John A. .
ANNUAL REVIEW OF MEDICINE, VOL 72, 2021, 2021, 72 :215-228
[5]   Epidemiology and Treatment of Peripheral Neuropathy in Systemic Sclerosis [J].
AlMehmadi, Bader A. ;
To, Fergus Z. ;
Anderson, Melanie A. ;
Johnson, Sindhu R. .
JOURNAL OF RHEUMATOLOGY, 2021, 48 (12) :1839-1849
[6]   PREDICTORS OF SURVIVAL IN SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
ALTMAN, RD ;
MEDSGER, TA ;
BLOCH, DA ;
MICHEL, BA .
ARTHRITIS AND RHEUMATISM, 1991, 34 (04) :403-413
[7]   Relevance of immunomodulatory therapy for interstitial lung disease in systemic sclerosis [J].
Aringer, Martin ;
Riemekasten, Gabriela .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2021, 35 (03)
[8]   CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [J].
Arruda, Lucas C. M. ;
Clave, Emmanuel ;
Douay, Corinne ;
Lima-Junior, Joao R. ;
Slavov, Svetoslav N. ;
Malmegrim, Kelen C. R. ;
Alberdi, Antonio Jose ;
Oliveira, Maria Carolina ;
Toubert, Antoine .
RHEUMATOLOGY, 2020, 59 (09) :E38-E40
[9]   Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients [J].
Arruda, Lucas C. M. ;
Malmegrim, Kelen C. R. ;
Lima-Junior, Joao R. ;
Clave, Emmanuel ;
Dias, Juliana B. E. ;
Moraes, Daniela A. ;
Douay, Corinne ;
Fournier, Isabelle ;
Moins-Teisserenc, Helene ;
Alberdi, Antonio Jose ;
Covas, Dimas T. ;
Simoes, Belinda P. ;
Lansiaux, Pauline ;
Toubert, Antoine ;
Oliveira, Maria Carolina .
BLOOD ADVANCES, 2018, 2 (02) :126-141
[10]   Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease [J].
Aschwanden, M. ;
Daikeler, T. ;
Jaeger, K. A. ;
Thalhammer, C. ;
Gratwohl, A. ;
Matucci-Cerinic, M. ;
Tyndall, A. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (07) :1057-1059